Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Identify whether a Backdoor Roth is right for you, focusing on income, taxes, and long-term retirement goals.
23,905 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Lowe's 2026 earnings outlook hinges on margin discipline and online growth. This guide breaks down what to watch and ...
When a CEO buys a large block of shares, investors take notice. This article dives into what the purchase of 250,000 ...
A Goldman Sachs AI skeptic warns the market’s patience may be running thin as OpenAI and Anthropic gear up for mega-I...
PayPal often trades at a compression multiple, which can look cheap on the surface. This article digs into what that ...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...
Both Microsoft and Palantir just hit 52-week lows, but the right move isn’t the same for every investor. This guide b...
Costco stock has flashed sell-side headlines and uncertain momentum. This guide breaks down what a dip means for COST...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Geopolitical headlines sparked a wild crypto swing. Bitcoin briefly climbed toward the $70K mark as traders weighed r...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...